Nina Worel, MD, Medical University of Vienna, Vienna, Austria, shares some insights into how T-cell exhaustion may impact patient outcomes following CAR-T therapy, and further highlights the possibility of using T-cell function as a novel biomarker. This interview took place at the EBMT-EHA 5th European CAR T-cell Meeting held in Rotterdam, The Netherlands.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

свернуть